-transparent.png){kind=logo}
A study was designed to see if the use of prophylactic progesterone vaginal suppositories (PVS) reduced the risk of spontaneous abortions in women with a history of at least one spontaneous abortion. PVS was employed during the luteal phase to the end of the first trimester. The dosage was initially 50 mg/day, but was increased according to the endometrial biopsy and doubled as soon as pregnancy was established. Only 10 women (10%) aborted, and 8 of these 10 were successful in their next PVS-treated pregnancies. Overall there were 12 losses in 132 pregnancies (9%) in these PVS-treated patients. Forty-two percent of untreated controls aborted (10/24). The results suggest that PVS is effective in reducing the risk of spontaneous abortions in high-risk patients.
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
August 1995,
The Journal of reproductive medicine,
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
June 1995,
BMJ (Clinical research ed.),
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
March 1990,
Lancet (London, England),
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
March 2001,
Obstetrics and gynecology,
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
February 1983,
American journal of obstetrics and gynecology,
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
March 1996,
Human reproduction (Oxford, England),
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
January 1990,
Pediatric pathology,
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
November 2016,
Vojnosanitetski pregled,
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
February 2016,
Prenatal diagnosis,
J H Check, and
J S Chase, and
K Nowroozi, and
C H Wu, and
H G Adelson
January 1992,
Gynecologic and obstetric investigation,
